646 related articles for article (PubMed ID: 19514077)
1. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
2. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
3. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
[TBL] [Abstract][Full Text] [Related]
4.
Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
[TBL] [Abstract][Full Text] [Related]
5. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.
Druschky A; Hilz MJ; Platsch G; Radespiel-Tröger M; Druschky K; Kuwert T; Neundörfer B
J Neurol Sci; 2000 Apr; 175(1):3-12. PubMed ID: 10785250
[TBL] [Abstract][Full Text] [Related]
7. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
[TBL] [Abstract][Full Text] [Related]
8. Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests.
Yamashita F; Hirayama M; Nakamura T; Takamori M; Hori N; Uchida K; Hama T; Sobue G
Clin Auton Res; 2010 Jun; 20(3):191-7. PubMed ID: 20127386
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy.
Oka H; Mochio S; Yoshioka M; Morita M; Onouchi K; Inoue K
Acta Neurol Scand; 2006 Apr; 113(4):221-7. PubMed ID: 16542160
[TBL] [Abstract][Full Text] [Related]
10. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
[TBL] [Abstract][Full Text] [Related]
11. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
12. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
Kikuchi A; Baba T; Hasegawa T; Sugeno N; Konno M; Takeda A
Parkinsonism Relat Disord; 2011 Nov; 17(9):698-700. PubMed ID: 21840242
[TBL] [Abstract][Full Text] [Related]
13. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
[TBL] [Abstract][Full Text] [Related]
14. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
Köllensperger M; Seppi K; Liener C; Boesch S; Heute D; Mair KJ; Mueller J; Sawires M; Scherfler C; Schocke MF; Donnemilier E; Virgolini I; Wenning GK; Poewe W
Mov Disord; 2007 Sep; 22(12):1771-6. PubMed ID: 17579357
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.
Treglia G; Stefanelli A; Cason E; Cocciolillo F; Di Giuda D; Giordano A
Clin Neurol Neurosurg; 2011 Dec; 113(10):823-9. PubMed ID: 21962800
[TBL] [Abstract][Full Text] [Related]
16. Correlation with sympathetic skin response,
Ozawa M; Morishima R; Shimizu T; Takahashi K
Neurophysiol Clin; 2024 Jul; 54(4):102956. PubMed ID: 38422587
[TBL] [Abstract][Full Text] [Related]
17. Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study.
Xu D; Zhu W; Huo L; Zhu S; Li F; Wang H
Parkinsonism Relat Disord; 2018 May; 50():69-73. PubMed ID: 29475590
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of relevance of
Alves Do Rego C; Namer IJ; Marcel C; Lefebvre F; Lagha-Boukbiza O; Renaud M; Tranchant C; Anheim M
J Neurol; 2018 Sep; 265(9):2033-2039. PubMed ID: 29956027
[TBL] [Abstract][Full Text] [Related]
19. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage.
Baschieri F; Calandra-Buonaura G; Doria A; Mastrolilli F; Palareti A; Barletta G; Solieri L; Guaraldi P; Martinelli P; Cortelli P
Parkinsonism Relat Disord; 2015 May; 21(5):477-82. PubMed ID: 25749354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
